Hyper-induction of pro-inflammatory cytokines, also known as a cytokine storm or cytokine
release syndrome (CRS), is one of the key aspects of the currently ongoing SARS-CoV-2 …

To date, no vaccines or effective drugs have been approved to prevent or treat COVID-19
and the current standard care relies on supportive treatments. Therefore, based on the fast …

COVID-19 is spreading and ravaging all over the world, and the number of deaths is
increasing day by day without downward trend. However, there is limited knowledge of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may lead to severe
disease in some cases, leading to acute respiratory distress syndrome, multi-organ failure …

The outbreak of coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) infection, has emerged in China in December 2019 …

Introduction The management of hospitalized COVID‐19 patients depends largely on
controlling the intensified inflammatory response known as the cytokine storm. Candidate …

Coronavirus Disease 2019 (Covid‐19) has a wide range of clinical manifestations. Studies
have estimated that while 30%–60% of Covid‐19 cases are asymptomatic, up to 5% of …

Despite extensive research to decipher the immunological basis of coronavirus disease
(COVID-19), limited evidence on immunological correlates of COVID-19 severity from MENA …

More than one year since its emergence, corona virus disease 2019 (COVID-19) is still
looming large with a paucity of treatment options. To add to this burden, a sizeable subset of …

Objectives Severe coronavirus disease 2019 (COVID-19) is associated with a dysregulated
immune state. While research has focused on the hyperinflammation, little research has …